J7311 Inj., retisert, 0.01 mg

Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 118 units per day (practitioner), rationale: Anatomic Consideration